Invidon 35 XR Tablet

Aperçu du produit

About Invidon 35 XR Tablet

Invidon 35 XR Tablet is a medication containing the active ingredient Trimetazidine, classified as Drug for angina pectoris sold under many brand names. Trimetazidine is a drug used in the treatment of angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart. Developed and first marketed by Laboratoires Servier (France), it is described as the first cytoprotective anti-ischemic agent.

Key Benefits & Uses

• Used for: Trimetazidine is a drug used in the treatment of angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart
• Used for: Developed and first marketed by Laboratoires Servier (France), it is described as the first cytoprotective anti-ischemic agent
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Trimetazidine, the active ingredient in Invidon 35 XR Tablet, belongs to the Drug for angina pectoris sold under many brand names class. Its clinical use follows the authorised labelling for Trimetazidine-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Invidon 35 XR Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Invidon 35 XR Tablet for extended periods without medical advice.